{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:24Z","timestamp":1786988124153,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013840","name":"Biocenter Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["GO 565\/22-1"],"award-info":[{"award-number":["GO 565\/22-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejpb.2026.114989","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T15:44:19Z","timestamp":1768751059000},"page":"114989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A refined coadministration regime to mitigate immunological clearance of biomedical nanoparticles"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1786-9589","authenticated-orcid":false,"given":"Kathrin","family":"Schorr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2261-1398","authenticated-orcid":false,"given":"Johannes","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1847-2075","authenticated-orcid":false,"given":"Jan","family":"Birringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0909-6785","authenticated-orcid":false,"given":"Carsten","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1320-6820","authenticated-orcid":false,"given":"Miriam","family":"Breunig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0190-7811","authenticated-orcid":false,"given":"Achim","family":"Goepferich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.114989_b0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2026.114989_b0010","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1002\/jbm.a.34642","article-title":"Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy","volume":"101","author":"Mishra","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2026.114989_b0015","unstructured":"Role of nanoparticles in drug delivery system: a comprehensive review, 2017."},{"key":"10.1016\/j.ejpb.2026.114989_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ejpb.2026.114989_b0025","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1021\/acs.molpharmaceut.2c00528","article-title":"Modulating macrophage clearance of nanoparticles: comparison of small-molecule and biologic drugs as pharmacokinetic modifiers of soft nanomaterials","volume":"19","author":"Mills","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.114989_b0030","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1039\/D2BM00181K","article-title":"Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation","volume":"10","author":"Mills","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2026.114989_b0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.colsurfb.2017.07.014","article-title":"Contribution of Kupffer cells to liposome accumulation in the liver","volume":"158","author":"Samuelsson","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2026.114989_b0040","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","article-title":"Mechanism of hard-nanomaterial clearance by the liver","volume":"15","author":"Tsoi","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ejpb.2026.114989_b0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2011.09.098","article-title":"The journey of a drug-carrier in the body: an anatomo-physiological perspective","volume":"161","author":"Bertrand","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114989_b0050","doi-asserted-by":"crossref","first-page":"E10871","DOI":"10.1073\/pnas.1713390114","article-title":"Effect of removing Kupffer cells on nanoparticle tumor delivery","volume":"114","author":"Tavares","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.ejpb.2026.114989_b0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.smim.2017.08.013","article-title":"Nanoparticles and innate immunity: new perspectives on host defence","volume":"34","author":"Boraschi","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejpb.2026.114989_b0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.114989_b0065","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1007\/s00289-019-02924-7","article-title":"Nanoparticle opsonization: forces involved and protection by long chain polymers","volume":"77","author":"Wani","year":"2020","journal-title":"Polym. Bull."},{"key":"10.1016\/j.ejpb.2026.114989_b0070","article-title":"Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials","volume":"3","author":"Lu","year":"2023","journal-title":"Exploration (Beijing, China)"},{"key":"10.1016\/j.ejpb.2026.114989_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122605","article-title":"Biological features of nanoparticles: protein corona formation and interaction with the immune system","volume":"14","author":"Panico","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.114989_b0080","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1039\/C5TB01825K","article-title":"Materials design at the interface of nanoparticles and innate immunity","volume":"4","author":"Szeto","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2026.114989_b0085","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Da Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.114989_b0090","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/acs.nanolett.0c01011","article-title":"Overcoming nanoparticle-mediated complement activation by surface PEG pairing","volume":"20","author":"Pannuzzo","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2026.114989_b0095","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1021\/nl302638g","article-title":"PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics","volume":"12","author":"Perry","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2026.114989_b0100","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/anie.201304060","article-title":"Integrated antimicrobial and nonfouling zwitterionic polymers","volume":"53","author":"Mi","year":"2014","journal-title":"Angewandte Chemie (International ed. in English)"},{"key":"10.1016\/j.ejpb.2026.114989_b0105","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1021\/acsnano.9b08658","article-title":"Zwitterion and Oligo(ethylene glycol) synergy minimizes nonspecific binding of compact quantum dots","volume":"14","author":"Han","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.114989_b0110","doi-asserted-by":"crossref","first-page":"e2944","DOI":"10.1002\/jmr.2944","article-title":"Zwitterionic polymers in drug delivery: a review","volume":"35","author":"Harijan","year":"2022","journal-title":"J. Mol. Recog. JMR"},{"key":"10.1016\/j.ejpb.2026.114989_b0115","article-title":"Recent advances in cell membrane-camouflaged nanoparticles for cancer phototherapy","volume":"15","author":"Zhen","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2026.114989_b0120","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1039\/C8NR07730D","article-title":"Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth","volume":"11","author":"Zelepukin","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2026.114989_b0125","doi-asserted-by":"crossref","first-page":"26269","DOI":"10.1038\/srep26269","article-title":"Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes","volume":"6","author":"Qie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.114989_b0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal, \u201cself\u201d peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejpb.2026.114989_b0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biomaterials.2017.08.045","article-title":"Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance","volume":"147","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2026.114989_b0140","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.ymthe.2025.03.018","article-title":"CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery","volume":"33","author":"Papp","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2026.114989_b0145","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4155\/tde.13.54","article-title":"Engineering antiphagocytic biomimetic drug carriers","volume":"4","author":"Sawdon","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2026.114989_b0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2018.06.007","article-title":"Chloroquine and nanoparticle drug delivery: a promising combination","volume":"191","author":"Pelt","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2026.114989_b0155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/17425247.2017.1243527","article-title":"Strategies for improving drug delivery: nanocarriers and microenvironmental priming","volume":"14","author":"Khalid","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.114989_b0160","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.2147\/IJN.S258054","article-title":"Regulating Interactions between targeted nanocarriers and mononuclear phagocyte system via an esomeprazole-based preconditioning strategy","volume":"15","author":"Belhadj","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2026.114989_b0165","doi-asserted-by":"crossref","first-page":"13738","DOI":"10.1038\/s41598-017-14221-2","article-title":"A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery","volume":"7","author":"Wolfram","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.114989_b0170","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.6836294","article-title":"Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles","volume":"220","author":"Proffitt","year":"1983","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejpb.2026.114989_b0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2020.12.004","article-title":"In vivo blockade of mononuclear phagocyte system with solid nanoparticles: Efficiency and affecting factors","volume":"330","author":"Mirkasymov","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114989_b0180","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1021\/acs.nanolett.0c00752","article-title":"A Nanoprimer to improve the systemic delivery of siRNA and mRNA","volume":"20","author":"Saunders","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2026.114989_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114708","article-title":"Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles","volume":"194","author":"Kumar","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.114989_b0190","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12274-019-2301-3","article-title":"Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration","volume":"12","author":"Howard","year":"2019","journal-title":"Nano Res."},{"key":"10.1016\/j.ejpb.2026.114989_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2017.04.024","article-title":"Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses","volume":"256","author":"Kang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114989_b0200","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.addr.2011.05.016","article-title":"Targeting the lymphatics using dendritic polymers (dendrimers)","volume":"63","author":"Kaminskas","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.114989_b0205","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.xphs.2021.10.009","article-title":"Physiologically based pharmacokinetic modeling of 3 hiv drugs in combination and the role of lymphatic system after subcutaneous dosing. Part 2: model for the drug-combination nanoparticles","volume":"111","author":"Perazzolo","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.114989_b0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1039\/D0NH00679C","article-title":"Enhancing subcutaneous injection and target tissue accumulation of nanoparticles via co-administration with macropinocytosis inhibitory nanoparticles (MiNP)","volume":"6","author":"Stack","year":"2021","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.ejpb.2026.114989_b0215","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1039\/D4NH00645C","article-title":"The quantity of ligand-receptor interactions between nanoparticles and target cells","volume":"10","author":"Schorr","year":"2025","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.ejpb.2026.114989_b0220","doi-asserted-by":"crossref","first-page":"34689","DOI":"10.1021\/acsami.0c10057","article-title":"Adenovirus-mimetic nanoparticles: sequential ligand-receptor interplay as a universal tool for enhanced in vitro\/in vivo cell identification","volume":"12","author":"Fleischmann","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2026.114989_b0225","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acsami.8b18843","article-title":"Ligand density and linker length are critical factors for multivalent nanoparticle-receptor interactions","volume":"11","author":"Abstiens","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2026.114989_b0230","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1038\/ncomms6717","article-title":"A lysine-rich motif in the phosphatidylserine receptor PSR-1 mediates recognition and removal of apoptotic cells","volume":"6","author":"Yang","year":"2015","journal-title":"Nat. Commun."},{"issue":"170","key":"10.1016\/j.ejpb.2026.114989_b0235","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.4049\/jimmunol.170.9.4840","article-title":"Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells","volume":"2003","author":"Callahan","year":"2003","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.ejpb.2026.114989_b0240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1208\/s12249-024-02837-3","article-title":"Phosphatidylserine and\/or sialic acid modified liposomes increase uptake by tumor-associated macrophages and enhance the anti-tumor effect","volume":"25","author":"Xu","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.114989_b0245","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201900427","article-title":"the effect of ligand mobility on the cellular interaction of multivalent nanoparticles","volume":"20","author":"Maslanka Figueroa","year":"2020","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2026.114989_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/conf.FBIOE.2016.01.02161","article-title":"Interaction of functionalized PEG-PLA\/PLGA nanoparticles with serum proteins and impact on nanoparticle stability and cell toxicity","volume":"4","author":"Kathrin","year":"2016","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.114989_b0255","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1080\/1061186X.2024.2390628","article-title":"Long-term residence and efficacy of adenovirus-mimetic nanoparticles in renal target tissue","volume":"32","author":"Walter","year":"2024","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2026.114989_b0260","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1021\/acsabm.2c01001","article-title":"Encapsulation of pioglitazone into polymer-nanoparticles for potential treatment of atherosclerotic diseases","volume":"6","author":"Groner","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ejpb.2026.114989_b0265","doi-asserted-by":"crossref","first-page":"37734","DOI":"10.1021\/acsami.4c07821","article-title":"Conditional cell-penetrating peptide exposure as selective nanoparticle uptake signal","volume":"16","author":"Walter","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2026.114989_b0270","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s10853-018-2819-x","article-title":"One-step fabrication of bicompartmental microparticles as a dual drug delivery system for Parkinson\u2019s disease management","volume":"54","author":"Parthipan","year":"2019","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ejpb.2026.114989_b0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejpb.2019.03.007","article-title":"Intracellular availability of poorly soluble drugs from lipid nanocapsules","volume":"139","author":"Bohley","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.114989_b0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo6638","article-title":"A single intravenous injection of cyclosporin A-loaded lipid nanocapsules prevents retinopathy of prematurity","volume":"8","author":"Bohley","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejpb.2026.114989_b0285","unstructured":"Empfehlung zur Substanzapplikation bei Versuchstieren, 2017."},{"key":"10.1016\/j.ejpb.2026.114989_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.07.048","article-title":"Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo","volume":"69","author":"Du","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2026.114989_b0295","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1039\/D2NH00543C","article-title":"How clathrin-coated pits control nanoparticle avidity for cells","volume":"8","author":"Zimmer","year":"2023","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.ejpb.2026.114989_b0300","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.114989_b0305","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","article-title":"The dose threshold for nanoparticle tumour delivery","volume":"19","author":"Ouyang","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ejpb.2026.114989_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121795","article-title":"Macrophage blockade using nature-inspired ferrihydrite for enhanced nanoparticle delivery to tumor","volume":"621","author":"Mirkasymov","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.114989_b0315","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle\u2013liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.114989_b0320","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1182\/blood.V124.21.5775.5775","article-title":"A phase II trial of chloroquine in combination with bortezomib and cyclophosphamide in patients with relapsed and refractory multiple myeloma","volume":"124","author":"Montanari","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejpb.2026.114989_b0325","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nri3087","article-title":"Studying the mononuclear phagocyte system in the molecular age","volume":"11","author":"Chow","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2026.114989_b0330","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1021\/acsnano.9b05679","article-title":"Overcoming the reticuloendothelial system barrier to drug delivery with a \u201cDon't-Eat-Us\u201d strategy","volume":"13","author":"Tang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.114989_b0335","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1128\/JVI.03287-13","article-title":"Role of phosphatidylserine receptors in enveloped virus infection","volume":"88","author":"Morizono","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ejpb.2026.114989_b0340","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nutres.2013.01.006","article-title":"Phosphatidylserine inhibits inflammatory responses in interleukin-1\u03b2\u2013stimulated fibroblast-like synoviocytes and alleviates carrageenan-induced arthritis in rat","volume":"33","author":"Yeom","year":"2013","journal-title":"Nutr. Res."},{"key":"10.1016\/j.ejpb.2026.114989_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060510","article-title":"Nanotechnology as a platform for the development of injectable parenteral formulations: a comprehensive review of the know-hows and state of the art","volume":"12","author":"Shetab Boushehri","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.114989_b0350","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7150\/thno.38198","article-title":"Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium","volume":"10","author":"Wan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejpb.2026.114989_b0355","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/10717544.2018.1474965","article-title":"Temporary suppression the sequestrated function of host macrophages for better nanoparticles tumor delivery","volume":"25","author":"Hao","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.114989_b0360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpharm.2013.01.059","article-title":"Premature drug release of polymeric micelles and its effects on tumor targeting","volume":"445","author":"Miller","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.114989_b0365","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejpb.2021.04.004","article-title":"Application of solid lipid nanoparticles as a long-term drug delivery platform for intramuscular and subcutaneous administration: In vitro and in vivo evaluation","volume":"163","author":"Elbrink","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.114989_b0370","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.2042-7158.2012.01599.x","article-title":"A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity","volume":"65","author":"Zhu","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.114989_b0375","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jac\/dkh260","article-title":"Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model","volume":"54","author":"Pandey","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2026.114989_b0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024374","article-title":"Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles","volume":"6","author":"Arvizo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.114989_b0385","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/acsptsci.4c00383","article-title":"Rethinking thin-layer chromatography for screening technetium-99m radiolabeled polymer nanoparticles","volume":"7","author":"Schorr","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejpb.2026.114989_b0390","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejpb.2019.03.007","article-title":"Intracellular availability of poorly soluble drugs from lipid nanocapsules","volume":"139","author":"Bohley","year":"2019","journal-title":"European J. Pharm. Biopharm.: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.v"},{"key":"10.1016\/j.ejpb.2026.114989_b0395","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12936-015-0570-1","article-title":"Simultaneous quantitation of chloroquine and primaquine by UPLC-DAD and comparison with a HPLC-DAD method","volume":"14","author":"Miranda","year":"2015","journal-title":"Malar. J."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112600010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112600010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:34:12Z","timestamp":1770284052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112600010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":79,"alternative-id":["S093964112600010X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.114989","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A refined coadministration regime to mitigate immunological clearance of biomedical nanoparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.114989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114989"}}